Table 1.
Variable | I2 (%) | k | # of effect sizes | OR | log(OR) | p | 95% CI | df |
---|---|---|---|---|---|---|---|---|
| ||||||||
Unadjusted intercept | 59.28 | 11 | 26 | 2.059** | 0.722 | .009 | [1.288–3.287] | 5.65 |
Adjusted intercept | - | 9 | 24 | 2.136* | 0.759 | .017 | [1.351–3.989] | 2.30 |
AIDS (proportion) | - | - | - | 2.239 | 0.806 | .611 | [0.005–1009.59] | 1.88 |
Nadir CD4 (cells/microliter) | - | - | - | 1.008 | 0.008 | .335 | [0.984–1.033] | 2.58 |
HIV duration (mean/median) | - | - | - | 0.971 | −0.029 | .669 | [0.005–1009.59] | 2.51 |
Note: The unadjusted intercept value is the overall effect size. Adjusted intercept refers to overall effect size after accounting for listed covariates. Models with degrees of freedom <4 are not trustworthy. All models were run separately and estimated using robust variance estimation meta-analysis. Abbreviations: k = number of outcomes included in the categoryOR = odds ratio; CI = confidence interval of the OR; df = degree of freedom; AIDS = acquired immune-deficiency syndrome; HIV duration = human immunodeficiency virus years since diagnosis.
p < .01.
p < .05.